The losses and job cuts for Tritium are a concern. While they appear to be opening up new markets that also says that they haven't got a hold on expenses and this may flow on to RFT.
I don't see the R&D facility as a threat to RFT. Why wouldn't they invite a strategic partner to participate at in their R&D?
In the meantime, Rectifier need to look at new opportunities and diversifying into different market sectors to sure up their business if the relationship with Tritium falters.
RFT Price at posting:
4.5¢ Sentiment: Buy Disclosure: Held
